Endovascular Treatment for eXtra-Large Ischemic Stroke — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Endovascular Treatment for eXtra-Large Ischemic Stroke — Stella

Recruiting

Back to Stroke, Acute Ischemic trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

China

The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan

Xiangtan Central Hospital, Xiangtan, Hunan

Key details

Sponsor

Zhongming Qiu

Collaborators

The First Affiliated Hospital, University of South China, Xiangtan Central Hospital

Enrollment target

~286 participants

Started

June 2024

Primary completion

October 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov